Zestmab 100 mg Injection
  1. Home
  2. Pharma Products
  3. RPG Life Sciences Ltd
  4. Zestmab 100 mg Injection

Zestmab 100 mg Injection

Zestmab 100 mg Injection contains rituximab 100 mg, a monoclonal antibody used for certain blood cancers and autoimmune disorders. It targets CD20-positive B cells and helps reduce abnormal or overactive B-cell activity. The injection is administered by a healthcare professional through intravenous infusion.

BUY NOW

Category

Rituximab binds to the CD20 antigen on B cells and supports their immune-mediated elimination. Zestmab is indicated for conditions including non-Hodgkin lymphoma, chronic lymphocytic leukaemia, and rheumatoid arthritis. The 100 mg presentation contains 100 mg of rituximab in a 10 mL single-use vial, providing a concentration of 10 mg/mL. The product is marketed by RPG Life Sciences Ltd and should be stored refrigerated at 2°C–8°C without freezing.

Technical Specification

Specification Details
Active Ingredient Rituximab
Strength 100 mg
Concentration 10 mg/mL
Pack Size 10 mL vial
Dosage Form Concentrate for solution for infusion
Manufacturer/Marketer RPG Life Sciences Ltd

Product Also Known As

Zestmab 100 mg Injection, Zestmab 100 mg/10 mL, Zestmab 100 Injection, Zestmab Rituximab Injection, Rituximab 100 mg Injection, Rituximab 100 mg/10 mL